Read this company snapshot
Daily valuation snapshot
Profound Medical Corp. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $6.9
- Market capitalization (USD)
- $252,074,898.6
- Price / earnings (TTM)
- Not reported
- Price / book
- 5.06
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research PROF in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research PROF in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing PROF with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $6.9 |
| Market capitalization (USD) | $252,074,898.6 |
| Price / earnings (TTM) | Not reported |
| Price / book | 5.06 |
No matching rows. Clear the filter to see all records.
Read PROF's valuation metrics
Company size
Profound Medical Corp. Common Stock's recorded market capitalization is $252,074,898.6. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
PROF's recorded price-to-book ratio is 5.06. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Profound Medical Corp. Common Stock with Aurora
Use the snapshot above to ask a specific question about PROF. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow PROF's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.